A
Abha Khanna
Researcher at University of Texas MD Anderson Cancer Center
Publications - 31
Citations - 2266
Abha Khanna is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Fluorescence in situ hybridization. The author has an hindex of 13, co-authored 30 publications receiving 2152 citations. Previous affiliations of Abha Khanna include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
Martin Korbling,Ruth L. Katz,Abha Khanna,Arnout C.C. Ruifrok,Gabriela Rondon,Maher Albitar,Richard E. Champlin,Zeev Estrov +7 more
TL;DR: All six recipients of sex-mismatched transplants showed evidence of complete hematopoietic donor chimerism and the presence of donor cells in the biopsy specimens did not seem to depend on the intensity of tissue damage induced by graft-versus-host disease.
Journal ArticleDOI
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Feng Jiang,Qi Qiu,Abha Khanna,Nevins W. Todd,Janaki Deepak,Lingxiao Xing,Huijun Wang,Zhenqiu Liu,Yun Su,Sanford A. Stass,Ruth L. Katz +10 more
TL;DR: Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer.
Journal ArticleDOI
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
Kanishka Sircar,Maisa Yoshimoto,Federico A. Monzon,Federico A. Monzon,Ismaël Hervé Koumakpayi,Ruth L. Katz,Abha Khanna,Karla Alvarez,Karla Alvarez,Guanyong Chen,Andrew Darnel,Armen Aprikian,Fred Saad,Tarek A. Bismar,Jeremy A. Squire +14 more
TL;DR: PTEN haploinsufficiency is common in hormone‐sensitive prostate cancer, though the incidence of genomic deletion and its downstream effects have not been elucidated in clinical samples of hormone refractory prostate cancer (HRPC).
Journal ArticleDOI
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
Ashish M. Kamat,Rian J. Dickstein,Fabrizio Messetti,Roosevelt Anderson,Shanna Pretzsch,Graciela Noguera Gonzalez,Ruth L. Katz,Abha Khanna,Tanweer M. Zaidi,Xifeng Wu,H. Barton Grossman,Colin P.N. Dinney +11 more
TL;DR: Fluorescence in situ hybridization results can identify patients at risk for tumor recurrence and progression during bacillus Calmette-Guérin immunotherapy and may be used to counsel patients about alternative treatment strategies.
Journal ArticleDOI
Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma
TL;DR: FISH can be performed on cervicovaginal liquid-based preparations to detect gain of 3q26 and is associated with HSIL and SCCA, and may be an adjunct to cytology screening, especially high-risk patients.